Consolidated statement of income

Continuing operations

Revenue

15,415

13,893

Cost of sales

(9,796)

(8,431)

Gross profit

5,619

5,462

Selling expenses

(3,387)

(3,211)

Impairment of ICI intangibles

(1,275)

–

General and administrative expenses

(1,108)

(1,091)

Research and development expenses

(353)

(338)

Other operating income/(expenses)

4

(73)

48

(6,196)

(4,592)

Operating income/(loss)

(577)

870

Financing income

5

154

62

Financing expenses related to pensions

5

(49)

(174)

Other financing expenses

5

(337)

(297)

Results from associates and joint ventures

11

25

22

Profit/(loss) before tax

(784)

483

Income tax

6

(260)

(128)

Profit/(loss) for the period from continuing operations

(1,044)

355

Discontinued operations

Profit for the period from discontinued operations

7

23

7

Profit/(loss) for the period

(1,021)

362

Attributable to:

- Shareholders of the company

(1,086)

285

- Minority interests

65

77

Profit/(loss) for the period

(1,021)

362

Earnings per share, in €

Continuing operations:

- Basic

16

(4.47)

1.20

- Diluted

16

(4.45)

1.18

Discontinued operations:

- Basic

16

0.09

0.03

- Diluted

16

0.09

0.03

Total operations:

- Basic

16

(4.38)

1.23

- Diluted

16

(4.36)

1.21